ArticleFrontiers in medicine2026
Systemic inflammatory ratios and their added value to cytology in cervical cancer detection: a multicenter study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cytology-based screening is central to cervical cancer prevention but may underestimate invasive disease. Low-cost adjunctive biomarkers could improve triage, particularly in settings with limited access to advanced diagnostics. We evaluated cytology-histology concordance and the utility of systemic inflammatory indices in women undergoing cervical conization. Methods: This multicenter retrospective study analyzed 1.142 women who underwent conization between 2021 and 2024 across three gynecological departments in Budapest, Hungary. Cytological and histological findings were grouped into four clinically relevant grades. Preoperative neutrophil-to-lymphocyte (NLR), platelet-to-lymphocyte (PLR), and lymphocyte-to-monocyte ratios (LMR) were derived from routine blood counts and assessed using non-parametric tests, receiver operating characteristic (ROC) analysis, logistic regression, and Bayesian updating. Results: Cytology underestimated histological severity in 13.9% of cases and missed 79.6% of invasive cancers (sensitivity 20.4%). NLR was significantly associated with histological outcomes and invasive cancer ( Conclusion: Complete blood count (CBC)-derived inflammatory markers, particularly NLR and LMR, may support cervical cancer triage strategies as low-cost adjuncts with rule-out potential; however, their limited discriminatory performance precludes their use as standalone diagnostic tools. They may still contribute to risk-adapted decision-making, especially in resource-limited settings, but require further prospective validation within multimodal strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.